Literature DB >> 9690197

Increases in retrospective accounts of war-zone exposure over time: the role of PTSD symptom severity.

L Roemer1, B T Litz, S M Orsillo, P J Ehlich, M J Friedman.   

Abstract

Retrospective reports of the frequency of war-zone exposure are commonly used as objective indices in studies investigating the mental health consequences of exposure to such stressors. To explore the temporal stability of these types of reports, we obtained frequency estimates of exposure to war-zone stressors at two time points from 460 U.S. soldiers who had served in the peace-keeping mission in Somalia. On average; soldiers demonstrated a significant increase in their frequency reports from initial (postdeployment) to subsequent (follow-up) assessment. Severity of posttraumatic symptomatology was uniquely associated with this change, indicating a possible systematic bias in which severity of symptoms leads to increased reports of stressor frequency. The implications of these findings for research in the field of traumatic stress are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9690197     DOI: 10.1023/A:1024469116047

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  37 in total

1.  Translational Challenges With Tonic Immobility.

Authors:  Lori A Zoellner
Journal:  Clin Psychol (New York)       Date:  2008-03-01

Review 2.  Inventorying stressful life events as risk factors for psychopathology: Toward resolution of the problem of intracategory variability.

Authors:  Bruce P Dohrenwend
Journal:  Psychol Bull       Date:  2006-05       Impact factor: 17.737

3.  War-related posttraumatic stress disorder in Black, Hispanic, and majority White Vietnam veterans: the roles of exposure and vulnerability.

Authors:  Bruce P Dohrenwend; J Blake Turner; Nicholas A Turse; Roberto Lewis-Fernandez; Thomas J Yager
Journal:  J Trauma Stress       Date:  2008-04

4.  Elevated rates of current PTSD among Hispanic veterans in the NVVRS: true prevalence or methodological artifact?

Authors:  Roberto Lewis-Fernández; J Blake Turner; Randall Marshall; Nicholas Turse; Yuval Neria; Bruce P Dohrenwend
Journal:  J Trauma Stress       Date:  2008-04

5.  Psychometric properties of the Adulthood Trauma Inventory.

Authors:  Matthew T Wittbrodt; Viola Vaccarino; Amit J Shah; Emeran A Mayer; J Douglas Bremner
Journal:  Health Psychol       Date:  2020-04-16       Impact factor: 4.267

6.  Post-traumatic stress disorder associated with natural and human-made disasters in the World Mental Health Surveys.

Authors:  E J Bromet; L Atwoli; N Kawakami; F Navarro-Mateu; P Piotrowski; A J King; S Aguilar-Gaxiola; J Alonso; B Bunting; K Demyttenaere; S Florescu; G de Girolamo; S Gluzman; J M Haro; P de Jonge; E G Karam; S Lee; V Kovess-Masfety; M E Medina-Mora; Z Mneimneh; B-E Pennell; J Posada-Villa; D Salmerón; T Takeshima; R C Kessler
Journal:  Psychol Med       Date:  2016-08-30       Impact factor: 7.723

Review 7.  A memory-based model of posttraumatic stress disorder: evaluating basic assumptions underlying the PTSD diagnosis.

Authors:  David C Rubin; Dorthe Berntsen; Malene Klindt Bohni
Journal:  Psychol Rev       Date:  2008-10       Impact factor: 8.934

8.  Effect of the 2010 Chilean earthquake on posttraumatic stress: reducing sensitivity to unmeasured bias through study design.

Authors:  José R Zubizarreta; Magdalena Cerdá; Paul R Rosenbaum
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

9.  Trajectories of posttraumatic stress among urban residents.

Authors:  Sarah R Lowe; Sandro Galea; Monica Uddin; Karestan C Koenen
Journal:  Am J Community Psychol       Date:  2014-03

10.  Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.

Authors:  Elisabeth B Binder; Rebekah G Bradley; Wei Liu; Michael P Epstein; Todd C Deveau; Kristina B Mercer; Yilang Tang; Charles F Gillespie; Christine M Heim; Charles B Nemeroff; Ann C Schwartz; Joseph F Cubells; Kerry J Ressler
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.